Pediatrix Medical Group (FRA:PDC) EPS without NRI: €1.84 (TTM As of Mar. 2026)


FRA:PDC Pediatrix Medical Group Inc FRA:PDC
57 GF Score
Price €22.80
GF Value €11.20
Valuation Significantly Overvalued
! 8 Warning Signs
View Full Analysis

What is Pediatrix Medical Group EPS without NRI?

Pediatrix Medical Group FRA:PDC +2.70% 57 EPS without NRI is €1.84 as of Mar. 2026. GuruFocus rates FRA:PDC with a GF Score™ of 57/100 and a GF Value™ of €11.20 (Significantly Overvalued). The stock has 8 warning signs investors should review. Among 512 Healthcare Providers & Services companies, Pediatrix Medical Group ranks worse than 56.05% on this metric.

Pediatrix Medical Group's earnings per share without non-recurring items for the three months ended in Mar. 2026 was €0.38. Its earnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2026 was €1.84.

During the past 12 months, Pediatrix Medical Group's average earnings per share (NRI) Growth Rate was 32.10% per year. During the past 3 years, the average earnings per share (NRI) Growth Rate was 7.10% per year. During the past 5 years, the average earnings per share (NRI) Growth Rate was 9.90% per year. During the past 10 years, the average earnings per share (NRI) Growth Rate was -8.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using Earnings per share without Non-Recurring Items (NRI) data.

The historical rank and industry rank for Pediatrix Medical Group's EPS without NRI or its related term are showing as below:

FRA:PDC' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: -32.4   Med: 12.5   Max: 101.8
Current: 7.1

During the past 13 years, Pediatrix Medical Group's highest 3-Year average Earnings Per Share (NRI) Growth Rate was 101.80% per year. The lowest was -32.40% per year. And the median was 12.50% per year.

FRA:PDC's 3-Year EPS without NRI Growth Rate is ranked worse than
56.05% of 512 companies
in the Healthcare Providers & Services industry
Industry Median: 11 vs FRA:PDC: 7.10

Pediatrix Medical Group's EPS (Diluted) for the three months ended in Mar. 2026 was €0.31. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was €1.76.

Pediatrix Medical Group's EPS (Basic) for the three months ended in Mar. 2026 was €0.32. Its EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2026 was €1.78.


Pediatrix Medical Group  (FRA:PDC) EPS without NRI Explanation

EPS without NRI removes onetime and unusual items from EPS, to provide investors with a more accurate measure of the company’s true earnings. The earnings are adjusted for items that are irregular or unusual in nature, and/or are non-recurring. This is calculated using Net Income (Continuing Operations) plus/minus any tax affected unusual Items and Goodwill Impairments/Write Offs. This can be used to fairly measure a company's profitability.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Pediatrix Medical Group EPS without NRI Related Terms


Pediatrix Medical Group EPS without NRI Historical Data

* Premium members only.

The historical data trend for Pediatrix Medical Group's EPS without NRI can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pediatrix Medical Group EPS without NRI Chart

Pediatrix Medical Group Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EPS without NRI
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.44 1.57 1.16 1.44 1.74

Pediatrix Medical Group Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EPS without NRI Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.31 0.46 0.57 0.43 0.38

FRA:PDC vs SEM, AGL, SGRY: EPS without NRI Comparison

For the Medical Care Facilities subindustry, Pediatrix Medical Group's PE Ratio without NRI, along with its competitors' market caps and PE Ratio without NRI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pediatrix Medical Group PE Ratio without NRI vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Pediatrix Medical Group's PE Ratio without NRI distribution charts can be found below:

* The bar in red indicates where Pediatrix Medical Group's PE Ratio without NRI falls into.


FRA:PDC
57GF Score
Pediatrix Medical Group Inc FRA:PDC
EPS without NRI is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Pediatrix Medical Group EPS without NRI Calculation

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Earnings Per Share without Non-Recurring Items is the amount of earnings without non-recurring items per outstanding share of the company's stock.

EPS without NRI for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €1.84

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS without NRI →
What does a EPS without NRI of €1.84 mean?
Pediatrix Medical Group (FRA:PDC) has a EPS without NRI of €1.84 as of Mar. 2026. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on Pediatrix Medical Group and its competitors. According to the industry distribution chart, Pediatrix Medical Group ranks #287 out of 512 companies in the Healthcare Providers & Services industry, placing it in the top 56.1%.
Is Pediatrix Medical Group's EPS without NRI too high?
Pediatrix Medical Group's current EPS without NRI is €1.84. Based on the distribution chart, Pediatrix Medical Group ranks #287 out of 512 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Pediatrix Medical Group has a GF Score™ of 57/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Pediatrix Medical Group's EPS without NRI compare to SEM and AGL?
According to the Healthcare Providers & Services industry distribution chart, Pediatrix Medical Group ranks #287 out of 512 companies for EPS without NRI. This places Pediatrix Medical Group in the lower half of its industry. The industry median EPS without NRI is 11.00. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS without NRI for a Healthcare Providers & Services company?
The median EPS without NRI among Healthcare Providers & Services companies is 11.00, based on 512 companies in the industry. Companies in the top quartile (top 25%) have a EPS without NRI significantly above this median, while those in the bottom quartile fall well below. However, EPS without NRI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS without NRI mean?
A high EPS without NRI can signal that a stock is expensive relative to its fundamentals. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on Pediatrix Medical Group and its competitors. For the Healthcare Providers & Services industry, the median EPS without NRI is 11.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Pediatrix Medical Group's current EPS without NRI is €1.84. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pediatrix Medical Group stock overvalued right now?
Based on GuruFocus' analysis, Pediatrix Medical Group (FRA:PDC) is currently considered Significantly Overvalued. The stock's GF Value™ is €11.20, compared to a current price of €22.80 — trading 103.6% above its estimated fair value. The current EPS without NRI is €1.84. Pediatrix Medical Group's overall GF Score™ is 57/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS without NRI calculated?
EPS without NRI is calculated from a company's financial statements. For Pediatrix Medical Group (FRA:PDC), the current EPS without NRI is €1.84 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Pediatrix Medical Group (FRA:PDC) Overvalued in 2026?

Based on GuruFocus' analysis, Pediatrix Medical Group stock appears to be overvalued. The current stock price of €22.80 is trading 103.6% above its estimated GF Value™ of €11.20. GuruFocus considers Pediatrix Medical Group to be Significantly Overvalued.

Key valuation signals for FRA:PDC:

  • EPS without NRI: €1.84
  • GF Value™: €11.20 vs. price of €22.80 (103.6% above fair value)
  • GF Score™: 57/100 with 8 warning signs

No single metric tells the full story. See the FRA:PDC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Pediatrix Medical Group Business Description

Other Exchanges MD:USA
Address 1301 Concord Terrace, Sunrise, FL, USA, 33323
Pediatrix Medical Group Inc provides physician services to hospitals, intensive care units, and other medical units. The services provided by the company include maternal care for expectant mothers, intensive care for premature babies, cardiology care for infants suffering from heart defects, and anesthesia care during surgeries, among others. The company operates only under one segment which provides physician services including newborn, maternal-fetal, and other pediatric subspecialty care. It generates majority of the revenue through neonatology and other pediatric subspecialties.
57GF Score

Get the complete analysis for FRA:PDC

EPS without NRI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€22.80
Price
€11.20
GF Value